Grifols on track to meet 2024 targets as core earnings rise
MADRID (Reuters) -Spanish drugmaker Grifols said on Thursday it was on track to meet its targets for the year after its net ...
Grifols holder Mason Capital against potential Brookfield deal
Mason Capital opposes Grifols sale to Brookfield Asset Management, raising concerns about the potential acquisition in the ...
Business Insider1d
Grifols price target raised to EUR 10 from EUR 9 at Deutsche Bank
Deutsche Bank raised the firm’s price target on Grifols (GRFS) to EUR 10 from EUR 9 and keeps a Hold rating on the shares. Published first on TheFly – the ultimate source for real-time, market-moving ...
Grifols on track to meet 2024 targets despite third-quarter profit drop
Spanish drugmaker Grifols said on Thursday it was on track to meet its targets for the year after its net profit fell 7.5% in ...
Mason Capital Management Highlights Corporate Governance Failures and Significant Shareholder Value Destruction Under Grifols Board of Directors
Mason Capital Management LLC ("Mason"), a registered investment advisor to funds and accounts holding approximately 2.1% of ...
Grifols Shares Rise After 3Q Sales Beat Views
Shares in Grifols jumped in early trading Friday after the company reported better-than-expected third-quarter sales driven by a strong performance of its biopharma division. Shares traded 4.7% higher ...
Grifols reports Q3 adjusted EBITDA of EUR 462M, up 26.7% in constant currency
Revenue increased by 12.4% in constant currencty to EUR 1.793B for the third quarter and adjusted EBITDA in Q3 grew by 26.7% cc to EUR 462M.
Bloomberg L.P.8d
Brookfield Seeks More Information on Grifols Related-Party Deals
Brookfield Asset Management is awaiting information from Grifols SA about related-party transactions as it seeks to complete its due diligence on the business, according to a person familiar with ...
Yahoo Finance13d
Grifols And 2 Other Stocks That Might Be Trading Below Estimated Value
Overview: Grifols, S.A. is a plasma therapeutic company operating in Spain, the United States, Canada, and internationally with a market cap of approximately €6.40 billion. Operations ...
Morningstar15d
Grifols Receives FDA Approval to Treat Surgical Bleeding in Pediatric Patients With its Fibrin Sealant Solution
Younger patients in the U.S. can now benefit from Grifols Fibrin Sealant (FS) and its positive effect on surgical outcomes, including a fast time to hemostasis Grifols surgical bleeding management ...
Yahoo Finance21d
Grifols Partners with BARDA for Proof-of-Concept Testing of Ocular Immunoglobulin as Treatment for Sulfur Mustard-Induced Eye Injury
BARCELONA, Spain, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global healthcare company and leading manufacturer of plasma-derived medicines, today announced it has ...
Yahoo Finance13d
Grifols And 2 Other Stocks That Might Be Trading Below Estimated Value
Overview: Grifols, S.A. is a plasma therapeutic company operating in Spain, the United States, Canada, and internationally with a market cap of approximately €6.40 billion. Operations: Grifols ...